Associated Capital Group, Inc.
Associated Capital Group, Inc. (AC) Financial Performance & Income Statement Overview
Review Associated Capital Group, Inc. (AC) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Associated Capital Group, Inc. (AC) Income Statement & Financial Overview
Review Associated Capital Group, Inc. AC income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.13M | $5.15M | $2.42M | $2.60M |
| Cost of Revenue | $1.10M | $6.45M | $5.11M | $3.94M |
| Gross Profit | $1.03M | -$1.30M | -$2.70M | -$1.35M |
| Gross Profit Ratio | $0.48 | -$0.25 | -$1.12 | -$0.52 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.87M | $0.00 | $4.21M | $442000.00 |
| Operating Expenses | $1.87M | $1.90M | $4.21M | $2.33M |
| Total Costs & Expenses | $2.97M | $8.35M | $9.33M | $6.27M |
| Interest Income | $5.02M | $7.51M | $11.14M | $7.86M |
| Interest Expense | $45000.00 | $39000.00 | $76000.00 | $69000.00 |
| Depreciation & Amortization | $89000.00 | $89000.00 | $91000.00 | $91000.00 |
| EBITDA | $10.68M | $1.31M | $30.49M | -$3.58M |
| EBITDA Ratio | $5.02 | $0.25 | $12.63 | -$1.38 |
| Operating Income | -$840000.00 | -$3.19M | -$6.91M | -$3.67M |
| Operating Income Ratio | -$0.39 | -$0.62 | -$2.86 | -$1.42 |
| Other Income/Expenses (Net) | $11.39M | $4.37M | $37.23M | $7.25M |
| Income Before Tax | $10.55M | $1.18M | $30.32M | $3.58M |
| Income Before Tax Ratio | $4.95 | $0.23 | $12.56 | $1.38 |
| Income Tax Expense | $2.78M | -$3.11M | $6.93M | $684000.00 |
| Net Income | $7.67M | $4.28M | $23.24M | $2.98M |
| Net Income Ratio | $3.60 | $0.83 | $9.62 | $1.15 |
| EPS | $0.36 | $0.20 | $1.09 | $0.14 |
| Diluted EPS | $0.36 | $0.20 | $1.09 | $0.14 |
| Weighted Avg Shares Outstanding | $21.17M | $21.22M | $21.27M | $21.39M |
| Weighted Avg Shares Outstanding (Diluted) | $21.17M | $21.22M | $21.27M | $21.39M |
Over the past four quarters, Associated Capital Group, Inc. demonstrated steady revenue growth, increasing from $2.60M in Q2 2024 to $2.13M in Q1 2025. Operating income reached -$840000.00 in Q1 2025, maintaining a consistent -39% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $10.68M, reflecting operational efficiency. Net income rose to $7.67M, with EPS at $0.36. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan